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This  paper  considers  the  hypothesis  that  modern  gynecological
practices  relating  to  sex-steroid  hormones  reflect  modern  sedentary
lifeways, along with pharmaceutical commercial pressures, to produce a
widespread  medical  perception  that  all  postmenopausal  women  need
estrogen replacement therapy to avoid osteoporosis  (bone fracture risk
resulting from low bone density). Like the concept of menopause itself,
the concept of universal menopausal osteopenia (low bone density) is a
modern medical construction. Numerous clinical trials have demonstrated
that  estrogen replacement  therapies  (ERT)  help women to  retain bone
mass  in  ageing  [33],  but  several  trials  have  also  shown  that  ERT  is
primarily effective in sedentary women who do not exercise [4; 5], Recent
studies of ancient human bones suggest that bone-mass in women was
higher  in  the  pre-agricultural  ancestral  past  due  to  greater  physical
activity  demands  and  greater  nutrient  density  than  are  common  in
modern corporeal lifeways [1; 23; 31]. From an evolutionary perspective,
the  metabolic  nature  of  bone  as  a  tissue  that  can  be  increased  or
reabsorbed in response not only to sex-steroid hormone levels but also to
dietary  mineral  and protein  status,  vitamin  D,  and  mechanical  loading
appears  adapted  to  an  environment  that  was  abundant  in  nutritional
micronutrients,  sunlight  exposure  and  regular,  demanding  physical
activity [9; 18]. 
Bone  is  highly  metabolic  tissue  that  is  continually  ‘turning-over’:
Osteoblasts build it and osteoclasts dissolve it  according to mechanical
stimulus  and  hormonal  signals,  and  relative  to  available  nutrients  -
particularly calcium, magnesium, protein and vitamin D [15]. Throughout
youth, the ratio of growth to reabsorption is highest, with a period of peak
bone-mass acquisition between ages 16-35 [15]. During pregnancy and
lactation, women become more bone-catabolic in order to draw from the
mineral reserves in bone to nourish infant development [18]. Bone loss
then  is  not  per  se  a  pathological  process.  After  age  50,  the  ratio  of
reabsorption to growth is generally higher in everyone, but if a healthy
reserve has been amassed in youth, this is unlikely to result in old-age
fractures  [15;  18],  However,  there  are  stressors  that  can  prohibit  the
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accumulation  of  a  healthy  bone  reserve  in  youth,  including  severe
malnutrition, specific deficiencies (such as calcium, magnesium, omega 3
fatty-acids,  protein,  vitamin  D)  [40;  49],  numerous  early  pregnancies,
major infectious diseases, lack of physical activity throughout the peak-
bone accumulation period [1; 31], the surgical removal of gonadal organs
that produce bone-protective hormones, and use of the contraceptive pill
[1; 2Unfortunately, several of these very stressors – especially vitamin D
deficiency, physically passive lifeways, women’s reproductive surgeries,
and use of the contraceptive pill - remain highly prevalent throughout the
affluent world today [30; 49].
This  paper  forms  part  of  an  integrative  biohumanistic  research
project on sex-differentiated ageing in the history of medicine, informed
both  by  recent  biomedical  and  anthropological  evidence,  and  by  an
approach  to  the  history  of  medical  concepts  that  considers  how  past
inheritances  continue  to  shape  research  and  clinical  practices.
Menopausal osteopenia is a disease category that appeared only in the
second  half  of  the  twentieth  century  in  the  context  of  the  postwar
pharmaceutical  investment  in  estrogen  replacement  therapies,  as
demonstrated by the late medical historian Gerald N. Grob in his 2014
monograph  Ageing  Bones [12].  Grob  argued  that  the  concept  of
menopausal  osteopenia  turns  a  process  of  normal  ageing  into  a
pathology,  and  presented  a  compelling  case  for  this  concept  as  an
example  of  “disease  mongering,”  referring  to  the  new  designation  of
pathologies  beyond  scientific  evidential  grounds,  in  the  service  of
commercial interests in the therapies pertaining to treat them. Globally,
numerous menopause and osteoporosis researchers and national medical
associations continue to support the use of  estrogen replacement as a
universal preventative treatment for all women over the age of 50 on the
basis  of  Dual-energy  X-ray  absorptiometry (DXA)  data  that  have
suggested  an  accelerated  bone  turnover  after  this  age  [13;  25].  The
medical  market  for  bisphosphonates  (drugs  that  present  loss  of  bone
density) has also massively grown as a treatment for those deemed ‘at
risk’  of  the  disease  on  the  basis  of  low  Bone  Mineral  Density  scores.
Imaging  technology  corporations,  too,  have  gained  from the  emerging
global obsession with scanning bodies to determine osteoporotic risk, in
the view that this risk itself indicates a growing disease epidemic in the
affluent world due to a rapidly ageing population [12]. 
In further support of Grob’s skeptical account, several studies, both
recent and historical, have demonstrated that bone turnover accelerates
in  women  before  the  decline  in  estrogen  associated  with  the  end  of
menses, suggesting that it is not a product of menopause per se, but of
the process of ageing more generally [11; 28]. Numerous studies funded
by  the  pharmaceutical  producers  of  estrogen-replacement  products,
examining  the  effect  of  estrogen  replacement  on  bone  density  have
certainly demonstrated their positive effect in preserving bone mass [33].
But other, publicly-funded, clinical trials comparing HRT with resistance
training have shown that the bone protective effect of estrogen is most
pronounced in sedentary women who do not exercise, in whom it  also
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increases fat mass, while resistance training without HRT increases bone
density and muscle mass with congruent fat loss [5; 39]. 
In  the  early-twentieth-century  discovery  of  the  sex-steroid
hormones,  it  was  initially  thought  that  testosterone  was  exclusively  a
male  hormone  and  estrogen  exclusively  a  female  one.  This  over-
simplification was quickly understood to be false when further enquiries
revealed the presence of all the sex-steroid hormones in both men’s and
women’s bodies [32]. Nonetheless, numerous researchers throughout the
twentieth century, and even still today, casually refer to these hormones
as if  they are  sex-specific.  The view of  estrogen as  the hormone that
regulates  women’s  entire  physiology  which  has  characterized  its
twentieth-century  history  [46],  continues  to  underly  current
misconceptions  about  osteoporosis  as  a  female-specific  disease  of
postmenopausal estrogen deficiency [12]. Certainly, the role of estrogen
in fetal development and in puberty is important for female-specific sex-
trait development, and its role in ovulation and conception is crucial for
female  reproductive  function.  But  women  are  not  only  estrogenic  and
typically produce more testosterone than estradiol [8]. Importantly, both
the androgens  and estrogen have been found to have bone-protective
effects both in men and women [21; 27; 44]. This is evident in several
recent studies of transgender hormone-bone interactions: MTF (male-to-
female)  transgender  women  on  long-term  estrogen  therapy  show
preservation of bone density in ageing, but so do FTM (male-to-female)
transgender men taking exogenous testosterone [43; 51].
However,  several  modern  pharmaceutical  hormone  practices
specific to women in fact suppress women’s natural testosterone: Both
the estrogen-only contraceptive pill and the use of menopausal estrogen
replacement.  The  mechanism  of  this  suppression  is  well  understood:
Exogenous  estrogenic  compounds  massively  upregulate  Sex-Hormone
Binding  Globulin  (SHBG)  and  Cortisol-Binding  Globulin  (CBH)  which
preferentially bind and inactivate the androgens rather than the estrogens
which trigger these proteins [20; 50]. Postmenopausal women on ERT thus
acquire abnormally high estrogen (for their age) with abnormally low Free-
Testosterone and DHEA [33]. The androgens, too, preserve bone density
in men and women, having anabolic  effects both directly  on bone and
indirectly via preserving muscle-mass and strength. [24; 26; 41] Thus, in
supplementing  one  bone-protective  and  mildly  anabolic  hormone  in
exogenous estrogen replacement, ERT-using-women sacrifice other even
more anabolic endogenous hormones that also protect bone. 
Since  the  1950s,  most  of  the  pharmaceutical  research  studies
demonstrating a bone-protective effect of ERT have included women who
have had  hysterectomies  and  oophorectomies,  often  as  a  prophylactic
measure  against  ovarian  cancer,  or  as  a  treatment  for  gynecological
disorders [46]. The loss of these organs, while producing minimal impact
on endogenous estradiol  levels,  results in a precipitous decline in both
testosterone  and  DHEA,  producing  a  deficiency  that  is  uncommon  in
women without surgery whose androgen levels remain relatively stable
throughout menopausal transition and after (declining in a gradual, linear
fashion with ageing, similarly to how they do in men) [6; 20]. Remember -
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testosterone  also  preserves  bone  density!  The  use  of  hysterectomy,
oophorectomy,  and  estrogen-based  therapies  to  prevent  osteoporosis
have  all  been  working  together  against  the  naturally  bone-anabolic
hormones that would otherwise be relatively abundant in postmenopausal
women.
The estrogenic contraceptive pill used throughout the late twentieth
century has similarly suppressed bioavailable testosterone and DHEA in
women by stimulating SHBG and CBG [33; 53]. Specific contractive pill
formulations have also been found to inhibit peak bone-reserve growth in
young women, both by disrupting endogenous estrogen’s anabolic effects
on bone, and by suppressing the androgens’ anabolic effects on both bone
and muscle [2; 14; 48] Given the widespread prevalence both of various
contraceptive-pill  formulations  and  of  hysterectomy  and  oophorectomy
throughout the affluent world since the 1960s, it might be considered that
these modern pharmaco-medical practices may themselves be among the
novel pressures of modernity contributing to the increased prevalence of
women’s  osteoporosis.  The  model  then  in  which  a  woman  who  is
predominantly sedentary and does no resistance exercise, lives primarily
indoors, takes the contraceptive pill for several years in her twenties, then
has  her  sex-hormone-producing  organs  surgically  removed,  then  takes
exogenous  estrogen,  conspires  to  produce  an  unusually  androgen-
deprived  and  osteopenic  older  woman,  who  is  far  more  likely  require
estrogen (and/or bisphosphonates) as a protective measure against old-
age  fractures.  Here  it  seems  plausible  that,  at  least  to  some degree,
‘menopausal  osteopenia’  has  been  iatrogenically  (i.e.,  unintentionally
harmful)  produced  by  the  pharmaceutical  industry  to  require  the  very
drugs sold by the corporations that have funded much of the research on
them. 
However, there are also reasons to consider that changes in bodily
lifeways  in  modern  affluent  cultures  have  also  helped  to  produce  the
current epidemic of elderly osteoporosis. Osteoporosis is most common in
some  of  the  most  affluent  countries  of  Northern  Europe  and  North
America, but not in all those with higher life-expectancy [12]. One of the
most likely reasons for the elevated osteoporotic risk from the postwar era
onwards is the increase in largely sedentary indoor lifestyles, comprising
jobs entailing all-day sitting, under artificial light, at a desk or in front of a
computer,  reliant on forms of  transportation  in  which the passenger is
physically  passive,  and on electronic  household devices that  spare the
user any major physical effort,  along with the increase in screen-based
leisure activities that also entail sitting. Many modern technologies that
only became widespread in the second half of the twentieth century have
resulted  in  far  less  physically-active  household  labor  and  childcare:
Consider the impact of the use of perambulators (wheeled baby carriages)
and of mechanized devices for washing clothes, dishes and cleaning, as
well  as refrigeration and running water supplies that permit  a massive
reduction in walking and carrying for the daily provision of the necessities
of  life  [29].  There  has  been  a  process  of  gradual  load  alleviation
throughout human history, but which has been massively amplified and
globalized since the end of World War Two [16]. To be free of physically-
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taxing and time-consuming chores can undoubtedly be a good thing for
creative and intellectual  flourishing,  but in their  place we need to find
other  ways  of  regularly  loading  our  bones  if  we wish  to  prevent  their
dissolution. 
Numerous  recent  studies  have  shown  that  resistance  training
preserves  bone  mass  in  older  adults,  both  in  those  who  lifted  heavy
weights only in their youth, and in those who take up lifting weights as
older  adults  [3;  17;  19;  46].  As  several  groups  of  researchers  have
recently shown, many earlier studies failed to confirm the bone-preserving
effects of resistance training in older adults due to poor study-design with
insufficient  joint-reaction-force stimulus and too short  duration to show
meaningful changes in bone density and architecture [4; 52]. Perceptions
that older women could not handle or would not comply with a program of
lifting  heavy  weights  appears  to  have  informed  many  of  these  study-
design  practices.  But  recent  research  has  shown  properly-instructed
compound  and  high-impact  lifting  to  be  well-received  and  have
spectacular  bone-preserving  effects  in  postmenopausal  women,
particularly in the presence of osteopenia and osteoporosis [4; 17; 47].
In proclaiming menopausal osteopenia a universal human disease,
some  researchers  have  cited  studies  of  historical  skeletal  remains
showing osteoporotic fractures in past human societies, such as Ancient
Egypt, the Roman Empire and medieval Europe, taking such examples as
evidence against  the role  of  physical  activity  in  preserving bone since
these  historical  populations  engaged  in  regular  manual  labor  and  still
appeared  to  have  suffered  osteopenia  [37].  However,  premodern
agricultural women experienced their own set of negative pressures on
bone mass, such as seasonal caloric undernutrition with resultant ovarian
suppression [1;  18],  widespread infectious diseases such as the bubonic
plague  and  tuberculosis,  8-10  pregnancies  per  woman  [9;  22],  and
mineral  and  protein  deficiencies  produced  by diets  focused heavily  on
cereal grains [23]. Given these factors, the high activity-levels of women
in these post-agricultural historical societes alone could not be expected
to compensate in preserving bone mass into old age. On the other hand,
studies of  the bones of  hunter-gathers and of  very early agriculturalist
populations  tell  a  rather  different  story:  Stone-age  skeletons  typically
show 15-20% higher bone mass than age-matched modern humans, with
archeologists proposing the main causes being greater activity levels and
greater nutrient density prior to the adoption of cereal-based agriculture
[30; 31; 36; 40]. One recent study has shown prehistoric female forearm
bones from Central Europe to have similar density and mass to those of
present-day elite competitive rowers [23].
With optimal nutrition and physical activity - and in the absence of
specific surgeries, medications, or diseases that increase bone turnover -
it seems likely that most women could avoid osteoporotic fractures in old
age without ever taking estrogen replacement [5].  Some forms of low-
dose ERT, particularly transdermal, may be relatively safe based on recent
research reviews, and the evidence of such therapies having benefit for
reduction of hot-flush symptoms in menopausal transition appears robust
[10;  42].  But  estrogen’s  prescription  as  a  universal  anti-osteoporotic
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prophylactic is a symptom of a unique historic nexus of modern medical,
pharmaceutical,  and  lifeway  disservices  to  women’s  strength  and
resilience. 
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